Literature DB >> 18056696

Prevalence and outcome of congenital heart disease in patients with neural tube defect.

Gülendam Koçak1, Cagatay Onal, Ayhan Koçak, Cemsit Karakurt, Ozkan Ates, Süleyman R Cayli, Saim Yologlu.   

Abstract

A prospective clinical study was designed to establish the risk factors, the prevalence, and the progress of congenital heart defects in children with neural tube defects. Study included 90 children with a mean age of 13.5 +/- 30.4 months. There were 53 (59%) patients with spina bifida occulta and 37 (41%) patients with spina bifida aperta. The overall prevalence of congenital heart disease was 27.8% (40.5% in spina bifida aperta and 18.9% in spina bifida occulta; P = .024). There was no statistically significant difference for maternal age, usage of periconceptional folate, and maternal diabetes between the patient and control groups. The authors conclude that congenital heart defects are more common than reported in neural tube defects, and screening echocardiograms are warranted. This should be kept in mind especially in patients requiring minor or major surgical procedures. Furthermore, routine obstetric examination and therefore the use of periconceptional folic acid during pregnancy is still lacking in our country.

Entities:  

Mesh:

Year:  2007        PMID: 18056696     DOI: 10.1177/0883073807309789

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

1.  Congenital Heart Disease and Myelomeningocele in the Newborn: Prevalence and Mortality.

Authors:  J Kevin Wilkes; William E Whitehead; Yunfei Wang; Shaine A Morris
Journal:  Pediatr Cardiol       Date:  2021-03-10       Impact factor: 1.655

2.  Is routine preoperative transthoracic echocardiography necessary in newborns with myelomeningocele?

Authors:  M M Vernon; D Powell; A H Schultz; T D Simon; D Doherty
Journal:  J Perinatol       Date:  2015-07-09       Impact factor: 2.521

3.  Scrib:Rac1 interactions are required for the morphogenesis of the ventricular myocardium.

Authors:  Veronika Boczonadi; Rachel Gillespie; Iain Keenan; Simon A Ramsbottom; Charlotte Donald-Wilson; Mariana Al Nazer; Patrick Humbert; Robert J Schwarz; Bill Chaudhry; Deborah J Henderson
Journal:  Cardiovasc Res       Date:  2014-08-18       Impact factor: 10.787

4.  Early Embryonic Expression of AP-2α Is Critical for Cardiovascular Development.

Authors:  Amy-Leigh Johnson; Jürgen E Schneider; Timothy J Mohun; Trevor Williams; Shoumo Bhattacharya; Deborah J Henderson; Helen M Phillips; Simon D Bamforth
Journal:  J Cardiovasc Dev Dis       Date:  2020-07-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.